Follow the 국전 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 국전 has logged 101 reports. Market capitalisation: €120.7bn. The latest transaction was disclosed on 1 July 2026 (Other). Among the most active insiders: 홍종호. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 101 declarations
국전 is a company listed on the XKRX market, specializing in the healthcare and pharmaceutical sector.